Skip to main content
. 2010 Nov 22;2(3):204–209. doi: 10.1111/j.2040-1124.2010.00082.x

Table 1.  Patient characteristics.

All subjects Group A (concomitant voglibose group) Group B (double mitiglinide group) P‐value (A vs B)
No. subjects (male, female)  20 (12, 8)  10 (7, 3)  10 (5, 5)
Age (years) 59.9 ± 11.4 57.8 ± 10.9 62.0 ± 12.1 N.S.
Duration of diabetes (years) 9.8 ± 6.0 7.1 ± 3.6 12.4 ± 6.8 0.0460
BMI (kg/m²) 24.6 ± 4.1 25.9 ± 2.6 23.2 ± 5.0 N.S.
HbA1c (%) 7.8 ± 0.6 8.1 ± 0.6 7.4 ± 0.3 0.0130
Fasting plasma glucose level (mg/dL) 167.9 ± 27.3 179.5 ± 30.8 156.3 ± 18.0 0.0410
SBP (mmHg) 126.9 ± 5.6 125.8 ± 6.4 128.0 ± 4.9 N.S.
DBP (mmHg) 72.6 ± 2.7 73.4 ± 3.4 71.8 ± 1.5 N.S.
TC (mg/dL) 213.0 ± 29.6 210.5 ± 23.6 215.5 ± 35.8 N.S.
LDL‐C (mg/dL) 128.7 ± 27.2 129.4 ± 16.9 128.0 ± 35.7 N.S.
TG (μU/mL) 123.0 ± 99.8 143.1 ± 122.2 102.9 ± 72.1 N.S.

BMI, body mass index; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; LDL‐C, low‐density lipoprotein cholesterol; N.S., not significant; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.